Back

Why do patients anticoagulated with DOACs due to non-valvular atrial fibrillation develop ischemic strokes?

27 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Atrial fibrillation - Stroke prevention Mechanisms for Stroke ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor James Milner

Hospital Center of Entre Douro and Vouga, Santa Maria da Feira (Portugal)

27 More presentations in this session

Presentation thumbnail
Professor P. Penson (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Doctor I. Cavallari (Rome, IT)
Abstract Slides
Presentation thumbnail
Doctor A. Jhand (Omaha, US)
Abstract Slides
Presentation thumbnail
Doctor A. Thandra (Omaha, US)
Abstract Slides
Presentation thumbnail
Doctor S. Pokorney (Durham, US)

Access the full session

Session thumbnail
Poster Session 4 - Atrial fibrillation - Stroke prevention

The Event

Event poster

ESC Congress 2018

27 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Direct oral anticoagulants vs warfarin in non-valvular atrial fibrillation. Meta-analysis, includes all published trials.
27 August 2021
thumbnail
Webinar
Cardiac monitoring after ischaemic stroke: evidence and clinical practice
14 June 2021
thumbnail
Webinar
Anticoagulation challenges in older subjects with multimorbidity
25 July 2023
thumbnail
Congress Presentation
Non valvular atrial fibrillation, contraindication to anticoagulation or antiplatelet therapy and heart team approach: a single centre experience
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources